Restech (Respiratory Technology Corporation), San Diego based innovator of the first airway reflux detection device, the Dx pH Measurement System, is pleased to announce the addition of Joel Richter, M.D. to its elite Scientific Advisory Board (SAB). Dr. Richter, former President of the American College of Gastroenterology, hails from Temple University where he is Chairman of the Department of Medicine.
An international leader in the advancement of esophageal and supraesophageal reflux detection and diagnosis, Dr. Richter was named to the peer-selected "America’s Best Doctors" list in 2005 and was recognized in the 2006 Philadelphia Magazine Top Doctors issue. He authored a validation study of Medtronic’s Bravo pH System that helped solidify the device as a standardized esophageal pH measurement test. Restech expects similar validation results with its Dx–pH Measurement System to standardize airway pH.
“This is a novel pH electrode specially built to work in the pharynx. We desperately need new technology which will help identify the subset of GERD patients where acid reflux is causing their extraesophageal symptoms,” insists Dr. Richter.
With his clinical experience and proven track record, Dr. Richter also brings a commanding reputation to the current debate over the impact of reflux on the esophageal and supraesophageal regions. The conflict pits otolaryngologists against gastroenterologists:
“Currently, the extraesophogeal GERD area is a battlefield between ENT and GI specialists with our poor patients in between. We desperately need new technology to accurately define those patients with acid related laryngeal and pulmonary symptoms. This (Restech) technology allows segregation of these patients and successful enrollment in placebo controlled PPI studies,” declares Dr. Richter.
Rounding out Restech’s SAB: Tom DeMeester, M.D., Keck School of Medicine, USC; Michael Vaezi, M.D., Ph.D., Vanderbilt University Medical Center; Gregory Postma, M.D., Medical College of Georgia; George Triadafilopoulos, M.D., Stanford University School of Medicine; and Gregory Wiener, M.D., private gastroenterology practice.
Restech will be attending the American Academy of Otolaryngology (AAO) Annual Meeting and exhibiting at the associated OTO EXPO, September 17-20, in Toronto, Canada at booth 1310.
Restech is a leader in engineering world-class medical technologies that provide comfortable, reliable solutions to assist physicians in the diagnosis of reflux related health problems. For more information on the Dx-pH Measurement System, call Debra Krahel at (800) 352- 1512 or visit http://www.restech.com.